K Pharma,Inc. 4896.T

Healthcare · Biotechnology · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$4.78M
Market Cap
$55.64M
Margin of Safety
-1063.4%
Intrinsic / Market Ratio
0.09

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

4.78M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

4.78M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

4.78M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

4.78M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

4.78M USD

from the sum above

Market Cap

55.64M USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.09×

the ratio the screener ranks by; Margin of Safety -1063.4% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 4.78M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).

The earnings power value was not computed (a NOPAT at or below zero this year), so the value is the book value today, 4.78M USD.

Market value

Market Cap55.64M USD

Today's price times the shares.

Value vs market

Margin of Safety-1063.4%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 4.78M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.

The projection was not made (a profit at or below zero in the latest three years), so the value is the book value today, 4.78M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFE

Not in the value

②Equity at Year 15, Today

Not in the value

Market value

Market Cap55.64M USD

Today's price times the shares.

Value vs market

Margin of Safety-1063.4%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 4.78M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (an operating profit at or below zero in the latest three years), so the value is the book value today, 4.78M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap55.64M USD

Today's price times the shares.

Value vs market

Margin of Safety-1063.4%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 6.02%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.43×Market Risk Premium 6.00%= 7.09%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC 25.00% (default): the statements print a tax provision of 17.46K USD on a pretax income of -6.34M USD, which gives no rate between 0 and the profit before tax, so the 25% default stands for the tax the interest saves.

Interest Expense =EBIT -6.32M USD−Pretax Income -6.34M USD= 21.04K USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 21.04K USDTotal Debt 10.12M USD×(1 − Tax Rate for WACC 25.00%)= 0.16%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 10.12M USDMarket Cap + Total Debt 55.64M USD + 10.12M USD= 15.39%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 84.61%×Cost of Equity 7.09%+Debt Weight 15.39%×Cost of Debt 0.16%= 6.02%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 15.87M USD − Total Liabilities 11.09M USD = Book Value Today 4.78M USD

Total Debt 10.12M USD − Cash and Short-Term Investments 14.62M USD = Net Debt Today -4.49M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 10.2%at most 5%passes11,622,600 / 11,604,600
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets3.0%at least -10.0%passes(-5.87M USD − -6.36M USD) ÷ 15.87M USD
Price to bookMarket Cap ÷ Book Value Today11.63×at most 3×does not pass55.64M USD ÷ 4.78M USD
Operating marginOperating Income ÷ Revenue—above 10.0%not measured-5.86M USD ÷ 0 USD
Revenue growthRevenue ÷ Revenue a Year Before − 1—above 10.0%not measured0 USD / 0 USD
Net cash(Cash − Total Debt) ÷ Market Cap8.1%above -30%passes(14.62M USD − 10.12M USD) ÷ 55.64M USD
Operating efficiencyOperating Income ÷ Gross Profit—above 25.0%not measured-5.86M USD ÷ 0 USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

751 USD

Enterprise value

8.00B USD

market cap plus net debt

EV / EBITDA

—

Price / book

11.28×

the provider's book

Price / earnings

—

Return on equity

-80.5%

the provider's, not the engine's

Profit margin

0.0%

Revenue growth

—

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

07.08M00

Gross profit

06.44M00

Operating income

-2.66M2.59M-5.33M-5.86M

EBITDA

operating income before depreciation and amortisation

-2.66M2.59M-5.38M-6.32M

Pretax income

-2.94M2.13M-5.38M-6.34M

Net income

-2.96M1.84M-5.40M-6.36M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

-2.79M2.11M-5.36M-6.04M

R&D

————
Balance sheet, year end

Total assets

10.35M23.45M15.00M18.81M

Total liabilities

288.46K1.48M604.19K10.71M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

10.06M21.97M14.40M8.10M

Total debt

——09.60M

Cash and equivalents

10.07M23.12M14.46M17.87M

Net PP&E

fixed assets after depreciation

——31.46K309.94K

Working capital

current assets less current liabilities

10.07M22.16M14.57M17.85M
Cash flow

Operating cash flow

-2.74M3.22M-6.27M-5.87M

Capital expenditure

paid out, so below zero

-225.62K-69.38K-92.39K-71.59K

Depreciation and amortisation

0———

Free cash flow

operating cash flow plus capital expenditure

-2.96M3.15M-6.36M-5.95M